This is my guess. If they can show the click chemistry approach works in patients then they have a platform that can be scaled out to any antibody.
CU6 - Media and Industry News, page-157
-
- There are more pages in this discussion • 234 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.30 |
Change
0.075(1.21%) |
Mkt cap ! $1.981B | |||
| Open | High | Low | Value | Volume |
| $6.29 | $6.30 | $6.25 | $2.207M | 350.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 8269 | $6.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.30 | 6049 | 11 |
View Market Depth
| Last trade - 12.21pm 15/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |